Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease

Lancet Neurol. 2019 Oct;18(10):911-912. doi: 10.1016/S1474-4422(19)30329-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Huntingtin Protein
  • Huntington Disease*
  • Nerve Tissue Proteins
  • Oligonucleotides, Antisense

Substances

  • Huntingtin Protein
  • Nerve Tissue Proteins
  • Oligonucleotides, Antisense